Caplin Point Laboratories Limited (BOM:524742)
India · Delayed Price · Currency is INR 2,520.55
+39.95 (1.61%)
At close: Aug 17, 2026
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 188.55 billion as of August 17, 2026. Its market cap has increased by 16.26% in one year.
Market Cap
188.55B
Enterprise Value
179.72B
Revenue
22.87B
Ranking
n/a
PE Ratio
28.42
Stock Price
2,520.55
ChartMarket Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 188.55B, an increase of 3,367,548.03%. That is a compound annual growth rate of 53.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 191.59B | 36.90% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 575.37B |
| GlaxoSmithKline Pharmaceuticals | 455.55B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 268.01B |
| Granules India | 212.63B |
| AstraZeneca Pharma India | 193.84B |
| Jubilant Pharmova | 136.92B |
| CORONA Remedies | 130.71B |